Arab Today, arab today mylan rebuffs teva again calls bid low insincere
Last Updated : GMT 06:51:55
Arab Today, arab today
Arab Today, arab today

Mylan rebuffs Teva again, calls bid low, insincere

Arab Today, arab today

Arab Today, arab today Mylan rebuffs Teva again, calls bid low, insincere

Generic drug company Mylan
New York - AFP

Generic drug company Mylan rejected for the second time Monday a $40.1 billion takeover offer from Israeli pharmaceutical power Teva, just days after Mylan's own bid for rival Perrigo was rebuffed.

Mylan's board said Teva's unsolicited offer "grossly undervalues" the company and does not fit its own business strategy.

The Teva proposal first announced on April 21 and reiterated Friday "would require Mylan's shareholders to accept what we believe are low-quality Teva shares in exchange for their high-quality Mylan shares, in a transaction that lacks industrial logic and carries significant global antitrust risk," the board said.

It also raised doubts about Teva management, saying its leadership team has "a poor record of delivering sustainable shareholder value."

"We believe that this is only a mere attempt by Teva to frustrate and distract Mylan from its business plan and strategy," the Mylan board said.

Mylan itself was criticized by smaller generic and over-the-counter drug maker Perrigo on Friday for its hostile $32.6 billion cash-and-shares offer.

Perrigo's board encouraged shareholders to reject the revised offer as much too low and continued to reject overtures from Mylan to enter talks.

A Teva-Mylan deal would form a $28 billion company that Teva said could generate $2 billion in annual savings, while expanding its specialty pharmaceutical business.

But Mylan says it believes antitrust regulators would block or stall the deal, disadvantaging shareholders.

A Mylan-Perrigo tie-up would create a company with more than $15 billion in annual sales and generate $800 million in annual savings from operational synergies, according to Mylan.

Mylan shares fell 3.7 percent in opening trade and Teva lost 2.0 percent while Perrigo gained 0.8 percent.

arabstoday
arabstoday

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

Arab Today, arab today mylan rebuffs teva again calls bid low insincere Arab Today, arab today mylan rebuffs teva again calls bid low insincere

 



Arab Today, arab today

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

Arab Today, arab today mylan rebuffs teva again calls bid low insincere Arab Today, arab today mylan rebuffs teva again calls bid low insincere

 



Arab Today, arab today France defies terrorism through tourism

GMT 15:18 2017 Saturday ,20 May

France defies terrorism through tourism
Arab Today, arab today Mai Al-Jeddawi presents décor ideas for Ramadan
Arab Today, arab today Sally Shaheen considers hosting a political show
View News in Arabic - Business: أخبار الشركات
Arab Today, arab today
Arab Today, arab today
Arab Today, arab today
Arab Today, arab today
 
 Arab Today Facebook,arab today facebook  Arab Today Twitter,arab today twitter Arab Today Rss,arab today rss  Arab Today Youtube,arab today youtube  Arab Today Youtube,arab today youtube
arabstoday arabstoday arabstoday arabstoday
arabstoday arabstoday arabstoday
arabstoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
arabstoday, Arabstoday, Arabstoday